Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Return on Sales (2020 - 2025)

Historic Return on Sales for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to 0.32%.

  • RxSight's Return on Sales fell 1400.0% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.2% for FY2024, which is 3500.0% up from last year.
  • RxSight's Return on Sales amounted to 0.32% in Q3 2025, which was down 1400.0% from 0.35% recorded in Q2 2025.
  • Over the past 5 years, RxSight's Return on Sales peaked at 0.15% during Q4 2024, and registered a low of 2.75% during Q2 2021.
  • Moreover, its 5-year median value for Return on Sales was 0.66% (2023), whereas its average is 0.97%.
  • The largest annual percentage gain for RxSight's Return on Sales in the last 5 years was 20100bps (2021), contrasted with its biggest fall of -95400bps (2021).
  • Quarter analysis of 5 years shows RxSight's Return on Sales stood at 1.87% in 2021, then skyrocketed by 48bps to 0.97% in 2022, then surged by 67bps to 0.32% in 2023, then skyrocketed by 54bps to 0.15% in 2024, then plummeted by -119bps to 0.32% in 2025.
  • Its Return on Sales stands at 0.32% for Q3 2025, versus 0.35% for Q2 2025 and 0.22% for Q1 2025.